EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomimetic M2 microglia membrane-coated nanoplatform for immune reprogramming and targeted edaravone delivery in ischemic stroke

Yanhong Ren, Peilong Li, Jiaping Li, Sheng Huang, Rutong Yu, Heng Zhao

Regenerative Biomaterials · 22.01.2026 · 13

DOI: 10.1093/rb/rbag119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 13.06.2026. Verfasst von Yanhong Ren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Joint Innovation Center for Brain Disorders,…. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Project of Tongren City, Guizhou Province, Guizhou Provincial Science and Technology Innovation Leading Talent Workstation for Stroke Brain Injury.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic stroke is a major cause of death and long-term disability worldwide, in which oxidative stress and neuroinflammation contribute substantially to secondary neuronal injury. Edaravone (EDA), a clinically approved free radical scavenger, has shown neuroprotective potential in ischemic stroke; however, its therapeutic efficacy is hindered by a short half-life, limited blood–brain barrier penetration and off-target effects. To overcome these limitations, we developed a biomimetic nanoplatform by encapsulating EDA within a nanoparticle (NP) core and coating it with membranes derived from M2-polarized microglia (EDA@M2 NPs). This hybrid system integrates potent antioxidant activity with inflammation-targeting and immunomodulatory capabilities. In a mouse model of middle cerebral artery occlusion, EDA@M2 NPs selectively accumulated in the ischemic hemisphere, significantly reduced infarct volume, suppressed neuronal apoptosis and improved neurological outcomes. Mechanistically, the nanoplatform not only scavenged excessive reactive oxygen species but also reprogrammed microglia from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 phenotype, thereby mitigating secondary neuroinflammation. By integrating targeted delivery, oxidative stress attenuation and immune microenvironment remodeling, this combinatorial therapeutic strategy markedly enhanced neuroprotection after ischemic stroke. Our findings demonstrate the translational promise of biomimetic nanotherapeutics for effective ischemic brain injury intervention.

Schlagwörter

Stichwörter der Autor:innen

biomimetic microgliaedaravoneimmune reprogrammingischemic strokeoxidative stress

Autor:innen und Institutionen

  • Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Joint Innovation Center for Brain Disorders, Capital Medical University, Beijing 100069, China.
  • Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Department of Ophthalmology, People's Hospital of Tongren, Guizhou 554300, China.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Project of Tongren City, Guizhou Province
  • Guizhou Provincial Science and Technology Innovation Leading Talent Workstation for Stroke Brain Injury

Zitieren

APA

Ren, Y., Li, P., Li, J., Huang, S., Yu, R., & Zhao, H. (2026). Biomimetic M2 microglia membrane-coated nanoplatform for immune reprogramming and targeted edaravone delivery in ischemic stroke. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag119

Vancouver

Ren Y, Li P, Li J, Huang S, Yu R, Zhao H. Biomimetic M2 microglia membrane-coated nanoplatform for immune reprogramming and targeted edaravone delivery in ischemic stroke. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag119

BibTeX
@article{Ren2026,
  author = {Ren, Yanhong and Li, Peilong and Li, Jiaping and Huang, Sheng and Yu, Rutong and Zhao, Heng},
  title = {Biomimetic M2 microglia membrane-coated nanoplatform for immune reprogramming and targeted edaravone delivery in ischemic stroke},
  journal = {Regenerative Biomaterials},
  year = {2026},
  volume = {13},
  doi = {10.1093/rb/rbag119}
}
Kostenlos starten →